IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Inovio Pharmaceuticals Inc

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q4 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Byrne Asset Management LLC
UNCHANGED
Shares4 from 4
Change0 (0%)
Value$5 (+$1)
Filed 2026-10-06
Status
Byrne Asset Management LLC
UNCHANGED4400%$4$5+$12026-10-06
Showing 1 of 1 institutions